Le Lézard
Classified in: Health
Subjects: LAW, EXE, RCL, PSF

Advisory - Unauthorized product containing synthetic cannabinoids sold from stores in Edmonton


OTTAWA, Aug. 24, 2017 /CNW/ -

Issue
Health Canada is advising Canadians of an unauthorized product called Brainfreeze Potpourri or Brainfreeze Herbal Incense that is labeled as an herbal product and contains synthetic cannabinoids. This product is being sold in speciality tobacco stores and head shops in Edmonton, Alberta, and may also be available for direct purchase through online retailers.

Synthetic cannabinoids, when inhaled or ingested, can lead to severe health risks, such as vomiting, chest pain, increased heart rate, vision blackouts, headaches, kidney damage, agitation, high blood pressure, and psychosis. Health Canada has received one report of a serious adverse reaction following use of the product.

What you should do
Do not purchase or consume products labelled as "synthetic marijuana," "smokeable herbal incense," "exotic herbal incense," "potpourri," or "legal high." Consuming these products may lead to serious adverse health effects. It is illegal for products to contain ingredients that are synthetic preparations of cannabis, which are regulated under the Controlled Drugs and Substances Act. Consumers who have these products in their possession are strongly advised to dispose of them immediately.

Retailers who have these products in their inventory should contact their legal counsel for advice on how to properly dispose of them. Synthetic cannabinoids are regulated through the Canadians Drugs and Substances Act and subjected to seizures from law enforcement. Legal action can be taken against the seller and consumers who have these products in their possession.

Who is affected
Any person who possesses, produces, sells, imports and/or exports a synthetic cannabinoid product.

Affected products

 

Product Name

Brainfreeze Herbal Incense

Brainfreeze Potpourri

 

Background
Synthetic cannabinoids are man-made chemicals that claim to mimic the effects of cannabis. These products can be found in stores, such as head shops and specialty tobacco stores, and online.

These products are believed to be smoked by consumers for their cannabis-like effects, despite the fact that they are often labelled as "not for human consumption".

What Health Canada is doing
Health Canada continues to work with its federal, provincial and municipal partners, including law enforcement, to:

Products containing controlled substances may be seized at points of entry into Canada and/or removed from retail outlets.

Related AWRs

Health Canada warns of risks related to synthetic marihuana products

For more information
Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.

To learn more about natural health products and other self-care products, visit Canada.ca/selfcare-products.

Également disponible en français

 

SOURCE Health Canada


These press releases may also interest you

at 14:20
The global gastroesophageal reflux disease (GERD) market  size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.2%  during the forecast period.  Rising geriatric...

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...



News published on and distributed by: